Summary of Testimony and Individual Findings The evidentiary review for Dr. Rosa Ivett Meza established her role as the essential operational accomplice within the illicit network created by Dr. Julliana Marissa De La Fuente at the San Juan IMSS Hospital. As a subordinate surgical resident, Dr. Meza was responsible for preparing post-mortem documentation, altering surgical cause-of-death reports, and maintaining cold-chain logistics for harvested organs prior to illegal transport. Forensic auditing revealed that while Dr. Meza did not perform the lethal surgical interventions that resulted in the 13 homicides directly committed by Dr. De La Fuente, she actively concealed the causes of death in at least 16 patient files and facilitated cold storage procedures. The defense argued coercion under hierarchy; however, digital communications confirmed financial remuneration received by Dr. Meza per organ processed, establishing voluntary participation. Sentence Mitigations and Method Determination The court recognized a distinct hierarchy of culpability between the two defendants. Dr. De La Fuente acted as the primary intellectual author and direct material executioner of the killings. Dr. Meza’s role, while indispensable to the operation's continuity, was secondary and logistics-focused. Consequently, the Tribunal determined that a differentiation in capital sentencing was legally justified. Under the inter-agency jurisdictional treaty with the ASTEN Autonomous Zone, capital punishment orders for both defendants were authorized for execution outside Mexican territorial restrictions. While the primary author received the maximum execution method (gas chamber), Dr. Meza was granted a mitigated capital sentence consisting of lethal injection, reflecting her status as an accessory rather than the primary perpetrator. Final Sentence Decree — Defendant Rosa Ivett Meza 1. Judgment: Found GUILTY of Complicity in Organ Trafficking, Accessory to Homicide, and Systematic Record Falsification. 2. Sentence: Condemned to DEATH BY LETHAL INJECTION. 3. Special Mitigation Note: Method selected based on secondary culpability and absence of direct material authoring in primary fatal incisions. 4. Transfer: Remanded to ASTEN high-security holding block under custody badge 2025-RM-LI.